Aprepitant

Half-Life (t½)
PO: 12h · IV: 12h
Formula
C23H21F7N4O3
Molecular Weight
534.43 g/mol
PubChem CID
135413536
Aliases
Emend

Pharmacological Mechanism

Selective NK1 (substance P) receptor antagonist — antiemetic for delayed chemotherapy-induced nausea. CYP3A4 substrate + moderate inhibitor + CYP2C9 inducer — DDI source during oncology regimens.

Half-Life & Elimination Curve (PO: 12h · IV: 12h)

100%50%25%12.5%0%0h0×t½12h1×t½24h2×t½36h3×t½48h4×t½60h5×t½0×t½ (0h): 100% remaining (~0.934 mg/L)1×t½ (12h): 50% remaining (~0.467 mg/L)2×t½ (24h): 25% remaining (~0.233 mg/L)3×t½ (36h): 12.5% remaining (~0.117 mg/L)4×t½ (48h): 6.3% remaining (~58.4 µg/L)5×t½ (60h): 3.1% remaining (~29.2 µg/L)
Plasma (PO)t½ Decay (12h)
  • 0×t½0h100% (0.934 mg/L)
  • 1×t½12h50% (0.467 mg/L)
  • 2×t½24h25% (0.233 mg/L)
  • 3×t½36h12.5% (0.117 mg/L)
  • 4×t½48h6.3% (58.4 µg/L)
  • 5×t½60h3.1% (29.2 µg/L)
Elimination t½12h (PO)
Rate Constant (ke)0.0578 h⁻¹
Time to Peak (Tmax)3.28h
Est. Peak (Cmax)0.934 mg/L
Clearance (CL)4.16 L/h
97% Washout (5×t½)60h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References